Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5G23D | — |
Kinrix was administered to a 13-month-old patient instead of Pediarix; Kinrix was administered to a 13-month-old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 13-month-old male patient who received DTPa-IPV (Kinrix) (batch number 5G23D, expiry date 21-AUG-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 28-JAN-2025, the patient received Kinrix. On an unknown date, the patient received Pediarix. On 28-JAN-2025, an unknown time after receiving Kinrix and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: Kinrix was administered to a 13-month-old patient instead of Pediarix) and inappropriate age at vaccine administration (Verbatim: Kinrix was administered to a 13-month-old patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 06-FEB-2025 The reporter reported that the Kinrix was administered to a 13-month-old patient instead of Pediarix which led to, wrong vaccine administered and inappropriate age at vaccine administration. The reporter stated that they had always re-vaccinated after 30 days an in because it was considered an invalid dose but their stated, they did not had to re-vaccinate because it was the same dose. The vaccine administration facility was the same as primary reporter.